Cargando…

Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap

The transverse myocutaneous gracilis (TMG) and the profunda artery perforator (PAP) flap are both safe choices for autologous breast reconstruction originating from the same donor region in the upper thigh. We aimed to compare the post-operative outcome regarding donor-site morbidity and quality of...

Descripción completa

Detalles Bibliográficos
Autores principales: Augustin, Angela, Pülzl, Petra, Morandi, Evi M., Winkelmann, Selina, Schoberleitner, Ines, Brunner, Christine, Ritter, Magdalena, Bauer, Thomas, Wachter, Tanja, Wolfram, Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406532/
https://www.ncbi.nlm.nih.gov/pubmed/36005186
http://dx.doi.org/10.3390/curroncol29080448
_version_ 1784774144298057728
author Augustin, Angela
Pülzl, Petra
Morandi, Evi M.
Winkelmann, Selina
Schoberleitner, Ines
Brunner, Christine
Ritter, Magdalena
Bauer, Thomas
Wachter, Tanja
Wolfram, Dolores
author_facet Augustin, Angela
Pülzl, Petra
Morandi, Evi M.
Winkelmann, Selina
Schoberleitner, Ines
Brunner, Christine
Ritter, Magdalena
Bauer, Thomas
Wachter, Tanja
Wolfram, Dolores
author_sort Augustin, Angela
collection PubMed
description The transverse myocutaneous gracilis (TMG) and the profunda artery perforator (PAP) flap are both safe choices for autologous breast reconstruction originating from the same donor region in the upper thigh. We aimed to compare the post-operative outcome regarding donor-site morbidity and quality of life. We included 18 patients who had undergone autologous breast reconstruction with a PAP flap (n = 27 flaps). Prospective evaluation of donor-site morbidity was performed by applying the same questionnaire that had already been established in a previous study evaluating TMG flap (n = 25 flaps) outcome, and results were compared. Comparison of the two patient groups showed equivalent results concerning patient-reported visibility of the donor-site scar and thigh symmetry. Still, the TMG group was significantly more satisfied with the scar (p = 0.015) and its position (p = 0.001). No difference was found regarding the ability to sit for prolonged periods. Donor-site wound complications were seen more frequently in the PAP group (29.6%) than in the TMG group (4.0%). Both groups expressed rather high satisfaction with their quality of life. Both flaps show minimal functional donor-site morbidity and high patient satisfaction. To minimize wound healing problems in PAP patients, thorough planning of the skin paddle is necessary.
format Online
Article
Text
id pubmed-9406532
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94065322022-08-26 Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap Augustin, Angela Pülzl, Petra Morandi, Evi M. Winkelmann, Selina Schoberleitner, Ines Brunner, Christine Ritter, Magdalena Bauer, Thomas Wachter, Tanja Wolfram, Dolores Curr Oncol Article The transverse myocutaneous gracilis (TMG) and the profunda artery perforator (PAP) flap are both safe choices for autologous breast reconstruction originating from the same donor region in the upper thigh. We aimed to compare the post-operative outcome regarding donor-site morbidity and quality of life. We included 18 patients who had undergone autologous breast reconstruction with a PAP flap (n = 27 flaps). Prospective evaluation of donor-site morbidity was performed by applying the same questionnaire that had already been established in a previous study evaluating TMG flap (n = 25 flaps) outcome, and results were compared. Comparison of the two patient groups showed equivalent results concerning patient-reported visibility of the donor-site scar and thigh symmetry. Still, the TMG group was significantly more satisfied with the scar (p = 0.015) and its position (p = 0.001). No difference was found regarding the ability to sit for prolonged periods. Donor-site wound complications were seen more frequently in the PAP group (29.6%) than in the TMG group (4.0%). Both groups expressed rather high satisfaction with their quality of life. Both flaps show minimal functional donor-site morbidity and high patient satisfaction. To minimize wound healing problems in PAP patients, thorough planning of the skin paddle is necessary. MDPI 2022-08-11 /pmc/articles/PMC9406532/ /pubmed/36005186 http://dx.doi.org/10.3390/curroncol29080448 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Augustin, Angela
Pülzl, Petra
Morandi, Evi M.
Winkelmann, Selina
Schoberleitner, Ines
Brunner, Christine
Ritter, Magdalena
Bauer, Thomas
Wachter, Tanja
Wolfram, Dolores
Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap
title Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap
title_full Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap
title_fullStr Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap
title_full_unstemmed Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap
title_short Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap
title_sort donor-site morbidity and quality of life after autologous breast reconstruction with pap versus tmg flap
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406532/
https://www.ncbi.nlm.nih.gov/pubmed/36005186
http://dx.doi.org/10.3390/curroncol29080448
work_keys_str_mv AT augustinangela donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap
AT pulzlpetra donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap
AT morandievim donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap
AT winkelmannselina donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap
AT schoberleitnerines donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap
AT brunnerchristine donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap
AT rittermagdalena donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap
AT bauerthomas donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap
AT wachtertanja donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap
AT wolframdolores donorsitemorbidityandqualityoflifeafterautologousbreastreconstructionwithpapversustmgflap